YLYun Liu

Yun Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yun Liu has a total of 202 co-authors. Here are the top co-authors by number of shared publications:

  • Wenyu Feng

    Department of Bone and Joint Surgery and Sports Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China

    13 shared publications
  • Haijun Tang

    Department of Spine Surgery, Academy of Orthopedics, Orthopaedic Hospital of Guangdong Province, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China

    12 shared publications
  • Mingxiu Yang

    Department of Spine and Osteopathy, The First Affiliated Hospital of Guangxi Medical University

    10 shared publications
  • Kai Luo

    Department of Orthopedics, Minzu Hospital of Guangxi Zhuang Autonomous Region

    9 shared publications
  • Shangyu Liu

    Department of Spine and Osteopathy, The First Affiliated Hospital of Guangxi Medical University

    9 shared publications
  • Shanhang Li

    Department of Bone and Soft Tissue Tumor, Guangxi Medical University Cancer Hospital, Nanning, Nanning 530021, China

    9 shared publications

Latest Publications

  • Open Access

    Uni-portal non-coaxial spinal endoscopic surgery (UNSES) for resection of a schwannoma in the C1-C2 foraminal region: experience in endoscopic resection and a case report

    by Hongcai Teng, Liang Mai, Biao Tang, Yiming Liu, Yangjie Cai, En Song, Yun Liu, Fake Meng

    Schwannomas in the upper cervical spine are relatively rare in clinical practice. Symptomatic patients require surgical resection, which is technically demanding; in some cases, combined cervical internal fixation is needed to maintain stability, and postoperative quality of life may be significantly affected. Uni-portal non-coaxial spinal endoscopic surgery (UNSES) provides a new option for the resection of such tumors. This study reports the case of a patient with an Eden type III C1-C2 schwannoma who underwent UNSES. The patient was a 47-year-old female admitted with a chief complaint of bilateral hand numbness accompanied by neck and back pain persisting for over four months. We precisely and effectively resected the schwannoma using UNSES, with preservation of cervical stability and no requirement for cervical internal fixation. At the three-month follow-up, the patient's Visual Analog Scale for pain decreased from 8 preoperatively to 1, the Japanese Orthopaedic Association score improved from 12 preoperatively to 16, and the Neck Disability Index declined from 23 preoperatively to 7. No postoperative complications occurred. UNSES enables the resection of schwannomas, offering the advantages of minimal invasiveness and rapid recovery. It holds potential benefits for the resection of spinal schwannomas, including those in the upper cervical spine, and provides a valuable reference for the selection of treatment strategies for schwannoma management.

  • Open Access

    scGPA: an LLM-assisted workflow for directional virtual gene perturbation analysis from single-cell transcriptomes

    by Haijun Tang, Hening Li, Qinghao Zhao, Xiang Zhou, Lei Peng, Yangjie Cai, Rongzhen Lin, Yufeng Li, Yiyi Yuan, Wenyu Feng, et al.

    Background: Existing virtual perturbation methods can often infer directional changes by comparing predicted post-perturbation expression profiles with control cells. However, workflows that directly return direction-specific downstream candidate genes together with confidence scores, evidence support and interpretable summaries remain limited. We developed scGPA, an LLM-assisted workflow system for directional single-cell virtual gene perturbation analysis. Methods: scGPA starts from raw single-cell RNA sequencing data and performs quality control, normalization, dimensionality reduction, clustering and cell-group selection. It then constructs cell-group-specific wild-type regulatory networks using repeated subsampling, principal component regression (PCR)/Ridge-based network inference and CP tensor denoising. Based on these networks, scGPA simulates dose-aware virtual knockdown of the target gene and applies signed perturbation propagation to estimate the magnitude and direction of downstream transcriptional responses. LLM assistance is used for marker-based cell-type annotation, evidence-guided candidate prioritization and user-facing biological summarization. Results: We benchmarked scGPA across five public Perturb-seq datasets and compared its performance with GEARS, scGPT and a random baseline. The overall correct prediction rate of scGPA was 23.0%, exceeding those of GEARS (20.7%), scGPT (15.1%) and the random baseline (13.6%). These results indicate that scGPA achieved a higher correct prediction rate than the two comparator models and the random baseline. We subsequently evaluated scGPA using a public osteosarcoma single-cell dataset and performed qRT-PCR validation in 143B osteosarcoma cells. Among genes with significant experimental changes, scGPA achieved a directional concordance of 76.9%. When all tested downstream genes were counted, 37.0% were directionally correct, 51.9% showed no significant change and 11.1% changed in the opposite direction. Conclusions: scGPA provides a practical workflow system for predicting and prioritizing direction-specific downstream transcriptional responses after target-gene perturbation. By integrating single-cell regulatory network inference, signed virtual perturbation and LLM-assisted interpretation, scGPA supports target-gene function inference and downstream mechanistic investigation from single-cell transcriptomic data.

  • Open Access

    Bispecific ANXA2/CD147 CAR-T cell therapy for osteosarcoma

    by Hai-Jun Tang, Wei Dai, Dan-Ting Xiao, He-Ning Li, Liang Xiong, Ming-Xiu Yang, Ji-Ming Liang, Zhuan Zou, Liang Mai, Shan-Hang Li, et al.

    Osteosarcoma is a highly malignant tumor with poor prognosis. Current CAR-T cell therapies for osteosarcoma are predominantly designed with single targets, but their efficacy remains unsatisfactory. In this study, a novel bispecific CAR-T cell was developed to provide an experimental basis for improving the therapeutic outcome of osteosarcoma. Single-cell RNA sequencing (scRNA-seq) identified two antigens highly expressed in osteosarcoma cells, ANXA2 and CD147, whose expression was further validated at the tissue level by qRT-PCR, flow cytometry, and immunohistochemistry. Based on a second-generation CAR backbone, a bispecific ANXA2/CD147 CAR-T construct was generated using magnetic bead sorting, primary T-cell culture, and lentiviral transduction, achieving a transduction efficiency of 47.1%. LDH release assays demonstrated that bispecific CAR-T cells exhibited significantly greater cytotoxicity against tumor cells than single-target and control groups. ELISA confirmed that bispecific CAR-T cells released higher levels of effector molecules, including GZMB and TNFα. In a subcutaneous CDX model, bispecific CAR-T cells displayed superior antitumor activity and greater T-cell infiltration. In a paw pad xenograft model, mice treated with bispecific CAR-T cells exhibited the smallest tumor volumes, lowest tumor weights, and reduced rates of lymph node metastasis. Furthermore, PDX models confirmed that bispecific CAR-T cells effectively suppressed osteosarcoma growth. ScRNA-seq of tumors derived from CDX models and immunohistochemistry revealed markedly increased infiltration of M1 macrophages in the bispecific group. Collectively, this study successfully generated a bispecific ANXA2/CD147 CAR-T cell with robust antitumor activity, providing a promising new strategy for the immunotherapy of osteosarcoma.

  • Formononetin Antagonizes Osteosarcoma Metastasis by Targeting CD44: An Integrated Multi-Omics Study

    by Wenyu Feng, Wei Dai, Gejin Wei, Shanhang Li, Hongcai Teng, Danting Xiao, Chaoyi Zhong, Feicui Li, Yun Liu

  • Open Access

    Uni-portal non-coaxial spinal endoscopic surgery on percutaneous hollow screw fixation for atypical hangman's fracture: a novel minimally invasive technique case report

    by Kai Luo, Fei Sun, Wenxian Huang, Haijun Tang, Mingxiu Yang, Wei Dai, Hongcai Teng, Shangyu Liu, Danting Xiao, Jianming Hu, et al.

    Purpose: This study reports a case of type B1 atypical Hangman's fracture and introduces a novel minimally invasive hollow pedicle screw insertion technique for the treatment of unstable Hangman's fracture. Methods: A 65-year-old male was admitted after an electric bicycle fall, presenting with occipital and cervical pain and numbness. Upon admission, his pain level was assessed as 7 on the Visual Analogue Scale (VAS), with a Neck Disability Index (NDI) score of 19. Cervical CT examination revealed multiple lucent lines in the axis, accompanied by diastasis, displacement, and fractures of the lateral transverse processes, leading to a diagnosis of type B1 atypical Hangman's fracture (AHF). The patient underwent percutaneous hollow pedicle screw fixation assisted by uni-portal non-coaxial spinal endoscopic surgery (UNSES). Results: Intraoperative blood loss was minimal, and postoperative CT confirmed satisfactory reduction of the axis fracture. At the 1-month follow-up, the patient's incision had healed well, symptoms had markedly improved (VAS score of 1, NDI score of 7). At the 10th-month follow-up, cervical CT showed significant fracture healing compared to previous examinations. By the 1-year follow-up, the patient's symptoms further improved (VAS score 0, NDI score 3). Conclusion: Percutaneous hollow pedicle screw fixation for AHF under the assistance of UNSES is feasible, offering advantages such as minimal invasiveness, a broad surgical field, and rapid postoperative recovery.

  • Open Access

    Uni-portal non-coaxial spinal endoscopic surgery via crossing midline approach for cervical radiculopathy: a case series of four patients

    by Hongcai Teng, Mingxiu Yang, Danting Xiao, Kai Luo, Wei Dai, Shangyu Liu, Jianming Hu, Jingxin Deng, Haiyi Quan, Yangjie Cai, et al.

    Introduction: Cervical radiculopathy typically presents with pain, numbness, and weakness in the affected nerve root distribution. When caused by bony foraminal stenosis, conventional posterior keyhole foraminotomy often necessitates extensive facetectomy, risking spinal instability. A modified approach preserving facets is therefore needed. This study assessed the feasibility and preliminary outcomes of uni-portal non-coaxial spinal endoscopic surgery (UNSES) with a crossing midline approach (CMA) for cervical radiculopathy. Methods: Four patients with cervical radiculopathy caused by bony foraminal stenosis underwent nerve root decompression via the CMA between March 2025 and April 2025. In this retrospective, single-center study, patients with a history of infection, trauma, or tumor were excluded. The surgical procedure involved three key steps: removal of V-point osteophytes using a high-speed drill, excision of herniated nucleus pulposus, and preservation of the lateral bony structure of the ipsilateral facet joint. Technical details of this novel approach are comprehensively described. Results: Mean operative time was 168.5 (98, 196) mins with blood loss of 15 (5, 50) mL. At 1 month, the Visual Analogue Scale (VAS) scores improved by 1 (0, 5) points and the Japanese Orthopaedic Association (JOA) scores improved by 16 (14, 17) points. Facet joint resection rate averaged 40.61% (18.21%, 47.05%). All four incisions healed within 2 weeks without complications at the 6-month follow-up. Conclusion: The UNSES technique via the CMA approach successfully achieves nerve root decompression while maximizing cervical facet joint preservation, without compromising spinal cord or adjacent neurovascular integrity. Importantly, it establishes a novel minimally invasive surgical option for cervical radiculopathy.

  • Open Access

    Pulmonary metastasectomy and survival in osteosarcoma: a systematic review and meta-analysis of surgery-related prognostic factors

    by Binyuan Ning, Xiaoting Luo, Gejin Wei, Wenyu Feng, Zhuan Zou, Shanhang Li, Liang Xiong, Jifeng Miao, Haijun Tang, Feicui Li, et al.

    Pulmonary metastasis is a major cause of disease progression and mortality in patients with osteosarcoma. The survival impact of pulmonary metastasectomy and the prognostic relevance of surgery-related factors remain incompletely defined. This systematic review and meta-analysis aimed to evaluate the association between pulmonary metastasectomy and survival outcomes and to identify key prognostic determinants. PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception to December 2025. Studies enrolling patients with histologically confirmed osteosarcoma and lung metastases that examined associations between surgery-related factors and survival outcomes were eligible. Outcomes included post-relapse survival (PRS) and post-metastasectomy overall survival (PMOS). Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using fixed- or random-effects models according to between-study heterogeneity. Twenty-one retrospective studies were included. Pulmonary metastasectomy was associated with improved post-relapse survival compared with no metastasectomy (HR = 0.29, 95% CI: 0.18–0.46). Complete resection consistently demonstrated a favorable association with survival across endpoints (PRS: HR = 0.21, 95% CI: 0.12–0.38; PMOS: HR = 0.31, 95% CI: 0.23–0.42). Bilateral pulmonary metastases were associated with inferior PMOS (HR = 1.56, 95% CI: 1.27–1.93), whereas the association with PRS did not reach statistical significance (HR = 1.37, 95% CI: 0.92–2.04). Video-assisted thoracoscopic surgery was associated with a modestly increased risk of mortality (HR = 1.69, 95% CI: 1.01–2.82). Across studies, a higher number of metastatic nodules was consistently linked to worse survival, although quantitative synthesis was limited by heterogeneous cutoff definitions. In observational studies, pulmonary metastasectomy is associated with improved survival in selected patients with osteosarcoma lung metastases, particularly when complete resection is achieved. Metastatic distribution, nodule burden, and surgical approach may influence prognosis. These findings support careful patient selection and individualized surgical decision-making while underscoring the need for prospective validation. The online version contains supplementary material available at 10.1186/s12957-026-04352-0.


  • Open Access

    Application of the far-lateral approach in uni-portal non-coaxial spinal endoscopic surgery: an evidence-based and Delphi consensus approach among Chinese expert opinions

    by Mengchen Yin, Yongpeng Lin, Pengfei Yu, Dong Wang, Fengtao Li, Shiyuan Hao, Kening Sun, Kuankuan Li, Yun Liu, Xin Zhang, et al.


  • Open Access

    Arthroscopic-assisted uni-portal non-coaxial endoscopic surgery for recurrent osteoid osteoma of the femoral neck: A case report

    by Hongcai Teng, Mingxiu Yang, Danting Xiao, Kai Luo, Wei Dai, Shangyu Liu, Jianming Hu, Jingxin Deng, Haiyi Quan, Yangjie Cai, et al.

    Rationale: Osteoid osteoma (OO) is a benign bone tumor predominantly affecting children and adolescents, commonly occurring in the diaphysis of long bones. Traditional open surgery causes damage to surrounding tissues, while radiofrequency ablation requires multiple fluoroscopic sessions, both of which may subject patients to unnecessary harm. However, when OO involves special anatomical structures such as the femoral neck, the difficulty of treatment is further increased. Arthroscopic-assisted uni-portal non-coaxial endoscopic surgery (AUNES), as a novel minimally invasive technique, integrates the advantages of both arthroscopic and endoscopic technologies. It enables precise lesion resection while minimizing tissue damage to the greatest extent. Therefore, this article explores the application value of this technique in femoral neck OO through recurrent cases. Patient concerns: A 10-year-old female presented with recurrent right thigh pain 11 months after initial open resection of femoral OO, characterized by nocturnal pain responsive to nonsteroidal anti-inflammatory drugs but with no signs of inflammation. Diagnoses: Imaging studies confirmed recurrent OO at the right femoral neck. Interventions: The patient underwent AUNES with single-portal tumor resection and allogeneic bone grafting under arthroscopic guidance. Outcomes: Complete pain resolution was achieved with no recurrence at 1-month follow-up. The technique demonstrated advantages including minimal incision (4 cm), low radiation exposure and early functional recovery. Lessons: AUNES is a promising treatment for recurrent femoral neck OO, particularly in pediatric patients. While this case shows excellent short-term outcomes, long-term follow-up and larger studies are needed to validate efficacy.

    • 20 December 2025
      • Vol. 45  (12) , 2726-2737

    [Polyphyllin VII inhibits osteosarcoma xenograft growth in mice by inducing ferroptosis via upregulating SOHLH1].

    by Danting Xiao, Haijun Tang, Mingxiu Yang, Hongcai Teng, Jiming Liang, Tianyu Xie, Wenyu Feng, Shangyu Liu, Wei Dai, Hening Li, et al.

    To investigate the inhibitory effect of polyphyllin VII (PP7) on osteosarcoma xenograft growth in mice and explore the underlying molecular mechanism. Ultra‑performance liquid chromatography‑tandem mass spectrometry was used to analyze the main active components of Paris polyphylla. Six nude mice bearing patient‑derived xenograft (PDX) were randomized into two groups for treatment with 2 mg/kg PP7 gavage or saline every other day for 28 days, and the changes in tumor volume and mass were measured. In cultured 143B and HOS cells, the effect of PP7 treatment (0, 1.25, 2.5, 5, and 10 μmol/L) on cell proliferation was assessed with CCK‑8 assay, and Transwell assays were employed to examine the changes in cell migration and invasion. The target of PP7 was predicted by integrated analyses with single‑cell RNA sequencing (scRNA‑seq), bulk RNA sequencing (bulk RNA‑seq) and molecular docking and verified using Western blotting. In osteosarcoma cells transfected with SOHLH1 siRNAs or a negative control sequence, the effects of PP7 treatment (5 μmol/L) on cell migration, invasion, ferroptosis, reactive oxygen species (ROS) production and lipid peroxidation (LPO) were analyzed. PP7 was identified as one of the major active constituents of Paris polyphylla. In the tumor-bearing mice, PP7 treatment significantly lower the tumor volume and mass. In 143B and HOS cells, PP7 concentration‑dependently inhibited cell proliferation, and at 5 μmol/L, PP7 significantly inhibited cell proliferation, migration and invasion. Multi‑omics analysis identified SOHLH1 as a potential target of PP7, and Western blotting confirmed that PP7 upregulated SOHLH1 expressions at both the mRNA and protein levels. SOHLH1 silencing obviously attenuated the inhibitory effects of PP7 on cell migration and invasion and reduced PP7‑induced ferroptosis. PP7 suppresses osteosarcoma xenograft growth in mice by inducing ferroptosis via upregulating SOHLH1 expression.